Sale!

MILAM 15

Original price was: 400.00৳ .Current price is: 360.00৳ .

  • Midazolam 15mg benzodiazepine for sedation
  • Treats short-term insomnia and preoperative sedation
  • Ideal for reducing muscle tension and inducing relaxation
  • Prescription required for safe usage

Generic
Milam 15 Tablet contains Midazolam, a benzodiazepine with 15mg of active ingredient.

Description
Milam 15, manufactured by SK+F, is a potent benzodiazepine sedative that treats short-term insomnia and provides pre-surgical or pre-diagnostic sedation. Known for its calming effects, Milam is primarily used under medical guidance.

Benefits
Milam 15 offers quick-acting relief from insomnia, muscle relaxation, and anxiety reduction. It provides controlled sedation, making it ideal for medical and preoperative use.

Ingredients
Each Milam 15 tablet contains 15mg of Midazolam as the active ingredient, a well-known benzodiazepine used in sedative therapy.

Uses and Doses
The oral dose for adults is 7.5-15 mg daily, and 7.5 mg is recommended for elderly or debilitated patients. Preoperative administration includes 15 mg taken 30-60 minutes before procedures. Depending on medical needs, Milam can also be administered intravenously or intramuscularly, with dosages adjusted per age and health condition.

Side Effects
Common side effects may include drowsiness, fatigue, headache, and muscle weakness, especially at therapy initiation. Intravenous use may lead to respiratory depression, apnea, or variations in blood pressure.

How to Use
Administer Milam 15 orally as prescribed by a healthcare provider. Take the recommended dose with water, ideally 30 minutes before the desired sedative effects or as advised for preoperative sedation.

Pregnancy & Lactation
Avoid Milam 15 during pregnancy and breastfeeding unless medically required, as Midazolam crosses into breast milk and may impact the fetus or infant.

Precautions and Warnings
Intravenous Milam should be administered slowly to avoid respiratory depression. Monitor elderly patients and those with severe health conditions closely.

Safety Information
Avoid using Milam 15 if you have severe respiratory or hepatic insufficiency or if you are hypersensitive to benzodiazepines.

Indications
Milam 15 is primarily indicated for short-term insomnia treatment, muscle relaxation, and preoperative sedation.

Pharmacology
Midazolam acts through GABA, a major inhibitory neurotransmitter, resulting in sedative, amnestic, and muscle-relaxant effects. It binds to GABA-A receptors, increasing efficacy by prolonging chloride channel opening.

Therapeutic Class
Milam 15 falls under benzodiazepine sedatives and hypnotics.

Storage Conditions
Store below 30°C, protected from light and moisture. Keep out of children's reach.

FAQ

  1. Can Milam 15 be used long-term?
    Milam 15 is intended for short-term use; prolonged use should be under strict medical supervision.
  2. Is Milam 15 safe during pregnancy?
    Milam 15 should be avoided during pregnancy unless necessary, as it can pass to the fetus through breast milk.
  3. What precautions should be taken with Milam 15?
    Intravenous administration should be slow, especially in elderly patients, to minimize respiratory risks.

Disclaimer
This product information is for general knowledge only and does not replace professional medical advice. Always follow your health care provider's directions and consult them with any questions.

Keywords: Milam 15, Midazolam tablet, SK+F, insomnia medication, sedative, benzodiazepine, short-term insomnia, pre-surgical sedative, Midazolam 15 mg, sedation, muscle relaxant, anxiety relief, tranquilizer, sedation therapy, GABA receptor, therapeutic class, sedative therapy, prescription drug, Midazolam benefits, SK+F pharmaceuticals.

Additional information

Weight 0.05 kg
Dimensions 2 × 1 × 1 in
Class -Dosage

Tablets

Size

15mg

Generics

Midazolam

pharmaceuticals

SK+F

Brand

Eskayef Pharmaceuticals Ltd.

Reviews

There are no reviews yet.

Be the first to review “MILAM 15”

Your email address will not be published. Required fields are marked *